Annals of Surgical Oncology

, Volume 10, Issue 10, pp 1131–1132 | Cite as

Sentinel Lymph Node Biopsy for Breast Cancer: Does Anybody Not Need One?

  • Hiram S. CodyIII


  1. 1.
    Krag DN, Weaver DL, Alex JC, et al. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993; 2: 335–40.PubMedCrossRefGoogle Scholar
  2. 2.
    Giuliano AE, Kirgan DM, Guenther JM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994; 220: 391–401.PubMedCrossRefGoogle Scholar
  3. 3.
    Veronesi U, Paganelli G, Viale G, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003; 349: 546–53.PubMedCrossRefGoogle Scholar
  4. 4.
    Wong SL, Edwards MJ, Chao C, et al. The effect of prior breast biopsy method and concurrent definitive breast procedure on success and accuracy of sentinel lymph node biopsy. Ann Surg Oncol 2002; 9: 272–7.PubMedGoogle Scholar
  5. 5.
    Haigh PI, Hansen NM, Qi K, et al. Biopsy method and excision volume do not affect success rate of subsequent sentinel lymph node dissection in breast cancer. Ann Surg Oncol 2000; 7: 21–7.PubMedCrossRefGoogle Scholar
  6. 6.
    Chung MH, Ye W, Giuliano AE. Role for sentinel lymph node dissection in the management of large (> or = 5 cm) invasive breast cancer. Ann Surg Oncol 2001; 8: 688–92.PubMedGoogle Scholar
  7. 7.
    Bedrosian I, Reynolds C, Mick R, et al. Accuracy of sentinel lymph node biopsy in patients with large primary breast tumors. Cancer 2000; 88: 2540–5.PubMedCrossRefGoogle Scholar
  8. 8.
    Olson JA, Jr, Fey J, Winawer J, et al. Sentinel lymphadenectomy accurately predicts nodal status in T2 breast cancer. J Am Coll Surg 2000; 191: 593–9.PubMedCrossRefGoogle Scholar
  9. 9.
    Tousimis E, Van Zee KJ, Fey JV, et al. The accuracy of sentinel lymph node biopsy in multicentric and multifocal breast cancers. J Am Coll Surg 2003; 197: 529–35.PubMedCrossRefGoogle Scholar
  10. 10.
    Liberman L, Cody HS, III. Percutaneous biopsy and sentinel lymphadenectomy: minimally invasive diagnosis and treatment of nonpalpable breast cancer. AJR Am J Roentgenol 2001; 177: 887–91.PubMedGoogle Scholar
  11. 11.
    Dupont EL, Kuhn MA, McCann C, et al. The role of sentinel lymph node biopsy in women undergoing prophylactic mastectomy. Am J Surg 2000; 180: 274–7.PubMedCrossRefGoogle Scholar
  12. 12.
    Klauber-DeMore N, Tan LK, Liberman L, et al. Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion? Ann Surg Oncol 2000; 7: 636–42.PubMedCrossRefGoogle Scholar
  13. 13.
    Cox CE, Nguyen K, Gray RJ, et al. Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS? Am Surg 2001; 67: 513–9.PubMedGoogle Scholar
  14. 14.
    Port ER, Fey J, Gemignani ML, et al. Reoperative sentinel lymph node biopsy: a new option for patients with primary or locally recurrent breast carcinoma. J Am Coll Surg 2002; 195: 167–72.PubMedCrossRefGoogle Scholar
  15. 15.
    Breslin TM, Cohen L, Sahin A, et al. Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer. J Clin Oncol 2000; 18: 3480–6.PubMedGoogle Scholar
  16. 16.
    Stearns V, Ewing CA, Slack R, et al. Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer. Ann Surg Oncol 2002; 9: 235–42.PubMedCrossRefGoogle Scholar
  17. 17.
    Waddington WA, Keshtgar MR, Taylor I, et al. Radiation safety of the sentinel lymph node technique in breast cancer. Eur J Nucl Med 2000; 27: 377–91.PubMedCrossRefGoogle Scholar
  18. 18.
    Montgomery LL, Thorne AC, Van Zee KJ, et al. Isosulfan blue dye reactions during sentinel lymph node mapping for breast cancer. Anesth Analg 2002; 95: 385–8.PubMedCrossRefGoogle Scholar
  19. 19.
    Fisher B, Wolmark N, Banes M. The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Gynecol Obstet 1981; 152: 765–72.Google Scholar
  20. 20.
    Intra M, Zurrida S, Maffini F, et al. Sentinel lymph node metastasis in microinvasive breast cancer. Ann Surg Oncol 2003: 10; 1160–5.PubMedCrossRefGoogle Scholar
  21. 21.
    Intra M, Veronesi P, Mazzarol G, et al. Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. Arch Surg 2003; 138: 309–13.PubMedCrossRefGoogle Scholar
  22. 22.
    Galper SR, Lee SJ, Tao ML, et al. Patient preferences for axillary dissection in the management of early-stage breast cancer. J Natl Cancer Inst 2000; 92: 1681–7.PubMedCrossRefGoogle Scholar
  23. 23.
    Simes RJ, Coates AS. Patient preferences for adjuvant chemotherapy of early breast cancer: how much benefit is needed? J Natl Cancer Inst Monogr 2001;146–52.Google Scholar

Copyright information

© The Society of Surgical Oncology, Inc. 2003

Authors and Affiliations

  1. 1.Breast Service, Department of SurgeryMemorial Sloan-Kettering Cancer CenterNew York
  2. 2.Memorial Sloan Kettering Cancer CenterNew York

Personalised recommendations